PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,147,000 | -51.9% | 24,227 | -38.1% | 0.01% | -50.0% |
| Q4 2020 | $2,386,000 | +15.2% | 39,110 | -11.7% | 0.02% | +14.3% |
| Q3 2020 | $2,072,000 | -12.4% | 44,310 | -4.9% | 0.01% | -26.3% |
| Q2 2020 | $2,365,000 | +10.7% | 46,610 | -2.7% | 0.02% | -5.0% |
| Q1 2020 | $2,137,000 | -3.7% | 47,910 | +3.7% | 0.02% | +33.3% |
| Q4 2019 | $2,219,000 | +32.2% | 46,210 | -6.9% | 0.02% | +50.0% |
| Q3 2019 | $1,678,000 | -22.8% | 49,610 | +2.7% | 0.01% | -33.3% |
| Q2 2019 | $2,174,000 | +254.1% | 48,310 | +195.9% | 0.02% | +275.0% |
| Q1 2019 | $614,000 | +10.8% | 16,327 | +1.2% | 0.00% | 0.0% |
| Q4 2018 | $554,000 | -33.8% | 16,127 | -9.4% | 0.00% | -33.3% |
| Q3 2018 | $837,000 | +35.4% | 17,800 | -2.7% | 0.01% | +50.0% |
| Q2 2018 | $618,000 | – | 18,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |